TABLE 3.
Therapeutic |
Nontherapeutic |
|||||
---|---|---|---|---|---|---|
Enrolled | Not Enrolled | P | Enrolled | Not Enrolled | P | |
Age, y | ||||||
15–19 | 31 (12%) | 237 (88%) | <.01 | 90 (34%) | 178 (66%) | <.01 |
20–24 | 10 (4%) | 241 (96%) | 14 (6%) | 237 (94%) | ||
25–29 | 16 (5%) | 290 (95%) | 30 (10%) | 276 (90%) | ||
30–34 | 14 (4%) | 357 (96%) | 69 (19%) | 302 (81%) | ||
35–39 | 33 (7%) | 470 (93%) | 84 (17%) | 419 (83%) | ||
Sex | ||||||
Male | 48 (6%) | 812 (94%) | .35 | 107 (12%) | 753 (88%) | <.01 |
Female | 56 (7%) | 783 (93%) | 180 (21%) | 659 (79%) | ||
Race/ethnicity | ||||||
White, non-Hispanic | 13 (4%) | 340 (96%) | .06 | 38 (11%) | 315 (89%) | <.01 |
African American | 2 (3%) | 78 (97%) | 6 (7%) | 74 (93%) | ||
Hispanic | 77 (7%) | 1011 (93%) | 212 (19%) | 876 (81%) | ||
Asian/Pacific Islander | 12 (7%) | 166 (93%) | 31 (17%) | 147 (83%) | ||
Hospital | ||||||
Children’s hospital | 29 (15%) | 162 (85%) | <.01 | 87 (46%) | 104 (54%) | <.01 |
Adult cancer hospital | 10 (3%) | 310 (97%) | 30 (9%) | 290 (91%) | ||
Public hospital | 65 (5%) | 1123 (95%) | 170 (14%) | 1018 (86%) | ||
Diagnosis | ||||||
Extracranial germ cell tumor | 7 (3%) | 237 (97%) | <.01 | 12 (5%) | 232 (95%) | <.01 |
Lymphoma | 15 (8%) | 171 (92%) | 12 (6%) | 174 (94%) | ||
Sarcoma | 9 (5%) | 156 (95%) | 17 (10%) | 148 (90%) | ||
Acute leukemia | 23 (15%) | 131 (85%) | 41 (26%) | 113 (73%) | ||
Breast carcinoma | 26 (19%) | 114 (81%) | 80 (57%) | 60 (43%) | ||
Other | 24 (3%) | 786 (97%) | 125 (15%) | 685 (85%) |
Abbreviation: AYAs, adolescents and young adults.